Finance

Lists
300573:SHE
Shenyang Xingqi Pharmaceutical Co Ltd
33,61 CN¥
+1,48%
(+0,49) 1D
16-окт., 15:04:49 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300573...
Open
33,40 CN¥
High
34,09 CN¥
Low
33,10 CN¥
Mkt. cap
12,05 млд
Avg. vol.
4,20 млн
Volume
4,60 млн
Dividend
2,94%
Quarterly dividend
0,25 CN¥
Ex-dividend date
2026-ж., 23-сен.
P/E ratio
15,19
52-wk high
59,07 CN¥
52-wk low
32,70 CN¥
EPS
2,21 CN¥
Shares outstanding
354,92 млн
No. of employees
2 миң
Open
33,40 CN¥
High
34,09 CN¥
Low
33,10 CN¥
Mkt. cap
12,05 млд
Avg. vol.
4,20 млн
Volume
4,60 млн
Dividend
2,94%
Quarterly dividend
0,25 CN¥
Ex-dividend date
2026-ж., 23-сен.
P/E ratio
15,19
52-wk high
59,07 CN¥
52-wk low
32,70 CN¥
EPS
2,21 CN¥
Shares outstanding
354,92 млн
No. of employees
2 миң
News stories
From web sources and news partners
Law360
Law360
·
45 мүнөт мурун
Nasdaq Sued Over Delisting Of Social Media Co.
Moomoo
Moomoo
·
23 мүнөт мурун
28.2 Close
Seeking Alpha
Seeking Alpha
·
45 мүнөт мурун
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
About Shenyang Xingqi Pharmaceutical Co Ltd
CEO-
Employees2,4 миң
Founded1977-ж., 24-мар.
Headquarters-
SectorPharmaceutical industry
Websitesinqi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
740,99 млн
569,12 млн
683,34 млн
717,54 млн
Cost of goods sold
123,12 млн
122,47 млн
122,64 млн
125,94 млн
Cost of revenue
123,12 млн
122,47 млн
122,64 млн
125,94 млн
Research and development expenses
63,36 млн
70,79 млн
84,47 млн
76,83 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230,42 млн
264,11 млн
241,35 млн
252,92 млн
Operating expense
286,99 млн
351,25 млн
331,32 млн
338,13 млн
Total operating expenses
410,12 млн
473,72 млн
453,96 млн
464,08 млн
Operating income
330,87 млн
95,41 млн
229,38 млн
253,46 млн
Other non operating income
-1,22 млн
475,40 миң
797,23 миң
-1,14 млн
EBT including unusual items
304,06 млн
111,50 млн
230,12 млн
252,18 млн
EBT excluding unusual items
330,73 млн
93,98 млн
230,10 млн
254,28 млн
Income tax expense
39,98 млн
14,56 млн
23,71 млн
28,19 млн
Effective tax rate
13,15%
13,05%
10,30%
11,18%
Other operating expenses
-10,95 млн
20,05 млн
4,96 млн
7,76 млн
Net income
264,08 млн
96,95 млн
206,41 млн
223,99 млн
Net profit margin
35,64%
17,03%
30,21%
31,22%
Earnings per share
-
-
-
-
Interest and investment income
462,25 миң
399,40 миң
408,35 миң
453,55 миң
Interest expense
-1,00 млн
-631,22 миң
-481,32 миң
-195,66 миң
Net interest expenses
-538,91 миң
-231,82 миң
-72,97 миң
257,89 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
353,72 млн
120,67 млн
254,64 млн
283,39 млн
Gain or loss from assets sale
74,80 миң
-52,54 миң
-
-7,97 миң
AI content may include mistakes. Learn more
Google колдонмолору